Gender and psychotropic drug use.
Gender and psychotropic drug use.
复制标题
性别和精神药物的使用。
DOI：
10.1097/00005650-199801000-00010
复制
发表时间：
1998
期刊：
影响因子：
3
通讯作者：
Simoni-Wastila,L
中科院分区：
文献类型：
--
作者：
Simoni-Wastila,L
研究目的：尽管研究证明女性更多地使用处方精神药物，但很少有人明确研究女性和男性在精神药物使用方面的差异。本研究探讨了精神药物总使用的性别差异，以及使用特定的治疗类别，并探讨了如何解释精神药物使用的其他因素因性别而异。方法。使用1989年全国门诊医疗调查（NAMCS）数据，逻辑回归分析被用来估计精神药物使用的概率，总和四个治疗类别-抗焦虑药，镇静催眠药，抗抑郁药和抗精神病药对于方程的性别是统计学上显着的，单独的logistic回归方程估计，以确定不同的解释变量，由gender.Results.The概率接受任何精神药物是55%以上，在办公室访问的女性比男性，所有其他常数。此外，性别是抗焦虑药和抗抑郁药使用的积极和重要的预测因素。估计抗焦虑药和antidepressnt使用的不同性别的变量包括诊断，医生的专业，和支付来源的office visit.Conclusions.Findings证实研究表明，女性比男性更有可能接受任何精神药物在办公室为基础的护理。这种性别差异只适用于抗焦虑药和抗抑郁药。此外，妇女和男子吸毒的预测因素存在显著差异。
Objectives.Although studies have documented women's greater use of prescribed psychotropic drugs, few have explicitly examined how women and men differ in psychotropic drug use. This study examines gender differences in aggregate psychotropic drug use, as well as use of specific therapeutic categories, and explores how other factors explaining psychotropic drug use vary by gender.Methods.Using 1989 National Ambulatory Medical Care Survey (NAMCS) data, logistic regression analysis is used to estimate the probability of psychotropic drug use in aggregate and for four therapeutic categories-anxiolytics, sedative-hypnotics, antidepressants, and antipsychotics. For equations where gender is statistically significant, separate logistic regression equations are estimated to determine the explanatory variables that vary by gender.Results.The probability of receiving any psychotropic drug is 55% greater in office visits by women than those by men, all else constant. Further, gender is a positive and significant predictor of anxiolytic and antidepressant use. Variables estimating anxiolytic and antidepressnt use that differ by gender include diagnosis, physician specialty, and payment source for the office visit.Conclusions.Findings confirm research that has demonstrated that women are more likely than men to receive any psychotropic drug in office-based care. This gender differential holds only for anxiolytics and antidepressants. In addition, there were significant differences in the predictors of drug use for women and men.